Foresite Capital
  • Strategy
  • Portfolio
  • People
  • Careers
Foresite News
Press Releases
Portfolio News

For press inquiries click here to contact us.

Remix Therapeutics

Remix Therapeutics debuts with $81M to ‘reprogram’ disease-causing RNA

December 10, 2020
Everlywell

Demand for at-home testing propels Everlywell to $175M in new funding

December 10, 2020
Maze Therapeutics

Chutes & Ladders—Sanofi CSO Nabel steps down in favor of insider Nestle

October 9, 2020
GRAIL, Inc.

Illumina buying cancer-screening spinout Grail in blockbuster $8B biotech deal

September 21, 2020
Evonetix

Evonetix Extends DNA Synthesis Partnership With Semiconductor Firm Analog Devices

September 9, 2020
Lyell Immunopharma

Orca Bio, Lyell Immunopharma pen new pact to open up CAR-T for solid tumors

September 2, 2020
Cerevance

Biotech Startup Cerevance Extends Series B to $65 Million

July 21, 2020
Kinnate Biopharma

Kinnate Biopharma Appoints Dr. Richard Williams as Chief Medical Officer

July 8, 2020
Inscripta

Writing in the Language of DNA: Kevin Ness on The Long Run

July 6, 2020
Relay Therapeutics

Relay Therapeutics tees up $200M IPO to push a trio of oncology meds

June 24, 2020
Page 1 of 1812345...10...»Last »

Please see important disclaimers in the Terms section.

Foresite Icon
Close
  • News
  • Blog
  • Foresite Labs
  • Contact Us
  • Home
  • Strategy
  • Portfolio
  • People
  • Careers
  • News
  • Blog
  • Foresite Labs
  • Contact
  • Investor Login
  • Terms
  • Privacy Policy

©2021 Foresite Capital Management, LLC

Site by Goodlab

Close